1. Home
  2. AVAH vs MLYS Comparison

AVAH vs MLYS Comparison

Compare AVAH & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVAH
  • MLYS
  • Stock Information
  • Founded
  • AVAH 1984
  • MLYS 2019
  • Country
  • AVAH United States
  • MLYS United States
  • Employees
  • AVAH N/A
  • MLYS N/A
  • Industry
  • AVAH Hospital/Nursing Management
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVAH Health Care
  • MLYS Health Care
  • Exchange
  • AVAH Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • AVAH 972.5M
  • MLYS 1.0B
  • IPO Year
  • AVAH 2021
  • MLYS 2023
  • Fundamental
  • Price
  • AVAH $4.72
  • MLYS $13.48
  • Analyst Decision
  • AVAH Hold
  • MLYS Strong Buy
  • Analyst Count
  • AVAH 4
  • MLYS 4
  • Target Price
  • AVAH $5.13
  • MLYS $27.00
  • AVG Volume (30 Days)
  • AVAH 493.0K
  • MLYS 667.1K
  • Earning Date
  • AVAH 08-07-2025
  • MLYS 08-12-2025
  • Dividend Yield
  • AVAH N/A
  • MLYS N/A
  • EPS Growth
  • AVAH N/A
  • MLYS N/A
  • EPS
  • AVAH 0.03
  • MLYS N/A
  • Revenue
  • AVAH $2,093,077,000.00
  • MLYS N/A
  • Revenue This Year
  • AVAH $9.36
  • MLYS N/A
  • Revenue Next Year
  • AVAH $4.43
  • MLYS N/A
  • P/E Ratio
  • AVAH $170.51
  • MLYS N/A
  • Revenue Growth
  • AVAH 9.05
  • MLYS N/A
  • 52 Week Low
  • AVAH $2.32
  • MLYS $8.24
  • 52 Week High
  • AVAH $6.19
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • AVAH 33.41
  • MLYS 35.32
  • Support Level
  • AVAH $5.31
  • MLYS $12.98
  • Resistance Level
  • AVAH $5.86
  • MLYS $16.67
  • Average True Range (ATR)
  • AVAH 0.26
  • MLYS 0.81
  • MACD
  • AVAH -0.10
  • MLYS -0.33
  • Stochastic Oscillator
  • AVAH 5.01
  • MLYS 13.56

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: